Fendrr transcription levels are negatively correlated with SOX4 protein levels in colon cancer; SOX4 protein is one of the binding targets of Fendrr, and Fendrr-mediated SOX4 inhibition may be essential in reducing colon cancer progression [25]. Here, SOX4 is linked to malignant colon neoplasm.